Federal Study Suggests Marijuana May Prevent Brain Damage in Stroke Victims 7/10/98

Drug War Chronicle, recent top items

more...

recent blog posts "In the Trenches" activist feed

SUBSCRIBE TODAY!!!

 - Kris Lotlikar

The National Institute on Mental Health has begun testing certain chemicals in marijuana for whether they might protect brain cells during a stroke.  THC and cannabidiol have both exhibited promising results, but the study is being concentrated on cannabidiol because of its lack of psychoactive properties.  Cannabidiol (CBD) proved to be a potent antioxidant in a test tube for protecting brain tissue exposed to toxic neurochemicals produced during a stroke.  Aiden Hampson, the team leader feels that CDB is a better candidate than the other chemicals found in marijuana.  Dr. Hampson's research team has now started giving intravenous CDB to rat and reveal the preliminary results are promising.  He stated to the UK Guardian, "We have something that passes the brain barrier easily, has low toxicity, and appears to be working in the animal trials.  So I think we have a good chance."

This discovery has special importance in the political arena, with medical marijuana initiatives possibly appearing on five states ballots this fall. "This study adds to the list of studies showing that there are more useful chemicals in the marijuana plant than just THC," Chuck Thomas, director of communication for the Marijuana Policy Project told The Week Online.  "This should be no surprise, considering that most patients prefer smoking marijuana to the THC pill (Marinol)."

Dr. Hampson claims that cannabidiol has so far been considered an inactive ingredient.  According to Paul Armentano, director of communication for NORML, however, cannabidiol has been studied for various uses in the past.  "This may look like a new discovery, but Israeli pharmacists have been studying it for about 4-5 years," commented Mr. Armentano to The Week Online.  Research on CDB has been conducted to treat epilepsy and Huntington's disease.  In Israel, a biotechnology company called Pharmos has developed a derivative of CDB called Dexanabinol, and has recently begun phase III testing, using human subjects.  Pharmos claims Dexanabinol can control neuronal cell death, the damage caused by head trauma and strokes.

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #49, 7/10/98 Government Kicks Off Billion Dollar Anti-Drug Ad Campaign | Feds File Motion Allowing Marshals to Shut Down Medical Marijuana Dispensaries | Oakland City Council Adopts Liberal Medical Marijuana Guidelines | Reports: Correlation Between Alcohol and Crime Much Stronger than Correlation Between Illicit Drugs and Crime | Federal Study Suggests Marijuana May Prevent Brain Damage in Stroke Victims | Anti-Needle Exchange H.R. 3717 Moves to Senate | Michigan Legislature Reforms "650 Lifer" Law | Heicklen Arrested at Start of 30 Hour Protest at Central Pennsylvania Festival of the Arts | Special Report: Drug Policy Down Under | Editorial: Running Ads vs. Protecting Kids
Mail this article to a friend
Send us feedback on this article
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Subscribe now!
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts

StoptheDrugWar.org: the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]